BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jun 14, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Aplidin plitidepsin: Phase III started

PharmaMar began the open-label, international Phase III ADMYRE trial comparing dexamethasone with and without 5 mg/m 2 IV Aplidin in 300 patients....

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >